Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
aimmune therapeutics
2
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
fda
2
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
2
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
advaxis
alder biopharmaceuticals
alexander hardy
alopecia areata
amarin
andrew oxtoby
arena pharmaceuticals
avapritinib
babies
blueprint medicines
boehringer ingelheim
breakup
What
bio
2
×
roundup
week
2
×
arena’s
big
bosley's
bosley’s
bounty
bridge
bucks
cas
ceo
cig
comeback
companies
corner
crime
crispr
deals
delivered
departure
editas
exit
expressing
guiding
ipo
katrine
life
little
medicine
moderna’s
moves
number
personnel
science
surprising
survey
thanks
thanksgiving
Language
Current search:
bio
×
week
×
" seattle top stories "
×
fda
×
" aimmune therapeutics "
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
